Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
RFK Jr. claims credit for Big Pharma's success in obesity decline
“Since President [Donald] Trump took office, obesity is down by 7% after 40 years of increasing,” Kennedy said after citing improvements in American eating habits, without citing GLP-1 uptake. The data are correct. Based on Gallup's…
Zealand Pharma - Transactions related to share buy-back program (week 37, 2026)
Company announcement No. 48 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 37, 2026) Copenhagen, Denmark, September 14, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…
Piramal Pharma Morpeth facility gets 7 US FDA observations
Piramal Pharma Limited's Morpeth facility in the UK has received seven observations after an inspection by the US Food and Drug Administration (US FDA), according to a regulatory filing. The US FDA conducted the inspection at the facility from…
Avalyn Pharma (NASDAQ:AVLN) Trading Up 6.8% - Time to Buy?
Avalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report) shares rose 6.8% during trading on Monday. The company traded as high as $36.16 and last traded at $35.86. 248,034 shares traded hands during mid-day trading, a decline of 21% from the average…
Squarepoint Ops LLC Purchases 49,005 Shares of NewAmsterdam Pharma Company N.V. $NAMS
Squarepoint Ops LLC boosted its position in shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) by 113.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange…
AI is hardly the first industry where the big guys demanded regulation
Rahm Emanuel over the weekend asserted that it was historic — unprecedented — that the CEOs of the biggest artificial intelligence companies want federal regulation of AI. I've served in two White Houses and in Congressional…
WINTON GROUP Ltd Invests $1.28 Million in Royalty Pharma PLC $RPRX
WINTON GROUP Ltd bought a new position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 22,800 shares of the…
Engineers Gate Manager LP Sells 205,781 Shares of BridgeBio Pharma, Inc. $BBIO
Engineers Gate Manager LP trimmed its holdings in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 84.4% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The…
Urogen Pharma $URGN Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lessened its position in shares of Urogen Pharma (NASDAQ:URGN - Free Report) by 98.2% during the second quarter, according to the company in its most recent 13F filing with the…
Teva Pharmaceutical Industries Limited (TEVA) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Teva Pharmaceutical Industries Limited (TEVA) Morgan Stanley 24th Annual Global Healthcare Conference September 14, 2026 8:30 AM EDT Richard Francis - President, CEO & Director Eric Hughes - Executive VP of Global R&D and Chief Medical Officer…
/afaqs/media/media_files/2026/09/14/healthok-2026-09-14-11-21-27.jpg)
Story Digital bags integrated creative mandate for HealthOK
Story Digital has been appointed as the integrated creative agency for Mankind Pharma's HealthOK. As part of the mandate, the agency will handle the brand's creative communication across digital and mainline platforms, with a focus on building…
Hims & Hers: Pivot To Branded Distribution Is Eating The Margins Alive (NYSE:HIMS)
Hims & Hers has shifted to a branded pharmaceutical distribution model, compressing gross margins from 76% to 64% in one year. Despite 38% revenue growth in Q2, adjusted EBITDA declined 27% YoY, and free cash flow turned negative $68M, signaling…
AI leaders calling for a slowdown right now is awfully convenient
Imagine a pharmaceutical company spends nearly four years touting a ground-breaking new medicine that will cure all diseases. Early evidence supporting those claims is limited, and massive questions remain, but the company continues to make…
Not all tech is under fire in Monday's selling, while investors seek refuge in defensive stocks
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. The S & P 500 and Nasdaq moved lower due to AI safety concerns Monday…
BLOC Names Jeff Raphael as the Incoming Executive Director
'Jeff brings a deep commitment to leadership, community, and talent development,' said Rob Perez, Co-Founder and Chairman of BLOC's Board of Directors. 'His experience and passion for building connections across our industry make him the right…
Receive a Daily briefing on Pharma Industry News
Get Started